跳至主要内容
临床试验/NCT00713999
NCT00713999已完成不适用

Study of Reproductive Health in Rural Madagascar With Emphasis on Urogenital Schistosomiasis and Sexually Transmitted Infections

University of Aarhus1 个研究点 分布在 1 个国家目标入组 680 人开始时间: 2001年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
680
试验地点
1
主要终点
Measurement of urogenital schistosomiasis and STI prevalence

研究概览

简要总结

A cross-sectional study of urogenital schistosomiasis and sexually transmitted infections (STI) prevalence and associated morbidity in a rural community in Madagascar. Clearance of infections and resolution of morbidity were subsequently studied in two phases following systematic anti-STI and anti-schistosoma treatment, respectively.

详细描述

The study was conducted in the Schistosoma haematobium high-endemic SIRAMA sugarcane plantation near the Ambilobe town in the northern province of Diego Suarez in Madagascar. A neighboring low-endemic village, Mataipako, was selected a control village. Participants aged 15 to 49 years old from SIRAMA were included in the study if positive for S.haematobium egg in urine.

A questionnaire addressing previous medical history and current urogenital symptoms was applied. A physical examination, including ultrasonophical (US) examination of urinary tract by transabdominal route, was undertaken. A pelvic examination, including transvaginal US was performed in women. In men, the prostate and the seminal vesicles were examined by transrectal US.

The following sexually transmitted infections (STI) were systematically assessed:

  • Neisseria gonorrheae
  • Chlamydia trachomatis
  • Mycoplasma genitalium
  • Trichomonas
  • Treponema pallidum
  • Herpes simplex 1 and 2

After baseline assessment, all participants (and partners) were systematically treated with an anti-STI regimen according to the existing guidelines by the Ministry of Health in Madagascar.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
15 Years 至 49 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • positive Schistosoma haematobium egg excretion in urine
  • signed written consensus

排除标准

  • negative Schistosoma haematobium egg excretion in urine

研究组 & 干预措施

STI/PZQ 1

Experimental

Baseline and post-treatment follow-up (anti-STI and praziquantel Rx)

干预措施: Treatment with anti-STI and anti-schistosoma regimens (Drug)

结局指标

主要结局

Measurement of urogenital schistosomiasis and STI prevalence

时间窗: 2 months

次要结局

  • Urogenital and STI associated morbidity(2 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Urogenital Schistosomiasis and Sexually Transmitted... | 临床试验